Search results for: 'vitro'

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

This research service provides market intelligence, analysis, and forecasts for the U.S. molecular diagnostics markets. The products discussed in this research service are in vitro diagnostic kits, consumables, and instruments. A detailed analysis is provided with regard to these products and the companies that manufacture and distribute them. The...

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

Non-alcoholic steatohepatitis (NASH) is a chronic liver condition whose prevalence across the globe continues to rise year on year. The liver disorder is considered very dangerous as its symptoms can be mistaken for other liver disorders and conditions. Moreover, the disease can quickly progress to result in liver failure for the patients. The incr...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

02 Mar 2021  |  North America  |  Market Outlook

Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021

Digital Transformation Leads to New Growth Strategies for Stakeholders

Infographics

×

The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the years events, healthcare delivery has accelerated its transformatio...

26 Dec 2018  |  North America  |  Market Outlook

Global Healthcare Market Outlook, 2019

With the Rise in Focus on Value-based Care, Technology Convergence will Drive Care Delivery Innovation

Infographics

×

Key Issues Addressed Key Benefits

Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in...

03 Jan 2018  |  North America  |  Market Outlook

Global Healthcare Industry Outlook, 2018

Value-based Care Will Continue to Drive Growth Opportunities for Emerging Technologies as They Move Out form Pilot Testing into Production Environments

Infographics

×

Key Issues Addressed Key Benefits

In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare industry in 2018. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for...